Literature DB >> 16417361

cis-[Rh2(mu-O2CCH3)2(CH3CN)6]2+ as a photoactivated cisplatin analog.

Daniel A Lutterman1, Patty K-L Fu, Claudia Turro.   

Abstract

The complex cis-[Rh2(mu-O2CCH3)2(CH3CN)6]2+ (1) exchanges the two axial CH3CN ligands for solvent molecules in water to yield cis-[Rh2(mu-O2CCH3)2(CH3CN)4(H2O)2]2+ (2). Photolysis of 2 in H2O results in the photoaquation of two equatorial acetonitrile ligands to yield [Rh2(mu-O2CCH3)2(CH3CN)2(H2O)4]2+ (3), which is able to covalently bind to free 2,2'-bipyridine (bpy) and 9-ethylguanine in solution, as well as double-stranded DNA (lambdairr >/= 455 nm). Complex 2 exhibits 20-fold lower cytotoxicity towards human skin cells than hematoporphyrin in the dark, and its toxicity increases by a factor of 34 when irradiated with visible light (400-700 nm, 30 min). This increase in cytotoxicity by 2 upon irradiation is approximately 7 times greater than that measured for hematoporphyrin. These properties make 2 a promising photo-cisplatin analog and a potential agent for photodynamic therapy. To our knowledge, 2 is the first metal-metal bonded complex to bind to DNA upon irradiation with visible light.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16417361     DOI: 10.1021/ja057620q

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  10 in total

1.  Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy.

Authors:  Jessica D Knoll; Claudia Turro
Journal:  Coord Chem Rev       Date:  2015-01-01       Impact factor: 22.315

2.  Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.

Authors:  Nicola J Farrer; Luca Salassa; Peter J Sadler
Journal:  Dalton Trans       Date:  2009-11-11       Impact factor: 4.390

3.  Dual Photoreactivity of a New Rh2(II,II) Complex for Biological Applications.

Authors:  Regina N Akhimie; Jessica K White; Claudia Turro
Journal:  Inorganica Chim Acta       Date:  2016-04-18       Impact factor: 2.545

4.  [Ru(bpy)2(5-cyanouracil)2]2+ as a potential light-activated dual-action therapeutic agent.

Authors:  Robert N Garner; Judith C Gallucci; Kim R Dunbar; Claudia Turro
Journal:  Inorg Chem       Date:  2011-08-31       Impact factor: 5.165

5.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

6.  Photoinduced interactions of two dirhodium complexes with d(GTCGAC)2 probed by 2D NOESY.

Authors:  Alycia M Palmer; Jessica D Knoll; Claudia Turro
Journal:  Dalton Trans       Date:  2015-02-28       Impact factor: 4.390

7.  A potent cytotoxic photoactivated platinum complex.

Authors:  Fiona S Mackay; Julie A Woods; Pavla Heringová; Jana Kaspárková; Ana M Pizarro; Stephen A Moggach; Simon Parsons; Viktor Brabec; Peter J Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-19       Impact factor: 11.205

8.  DNA interactions and photocatalytic strand cleavage by artificial nucleases based on water-soluble gold(III) porphyrins.

Authors:  Martin Haeubl; Lorenz Michael Reith; Bernadette Gruber; Uwe Karner; Norbert Müller; Günther Knör; Wolfgang Schoefberger
Journal:  J Biol Inorg Chem       Date:  2009-05-27       Impact factor: 3.358

Review 9.  New trends for metal complexes with anticancer activity.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Curr Opin Chem Biol       Date:  2008-01-25       Impact factor: 8.822

10.  Os2 -Os4 Switch Controls DNA Knotting and Anticancer Activity.

Authors:  Ying Fu; María J Romero; Luca Salassa; Xi Cheng; Abraha Habtemariam; Guy J Clarkson; Ivan Prokes; Alison Rodger; Giovanni Costantini; Peter J Sadler
Journal:  Angew Chem Int Ed Engl       Date:  2016-05-30       Impact factor: 15.336

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.